Join us for vision 73’s second event on June 4thth in Central London. While full details will be announced soon, you can register here.
In March vision 73 was honoured to host Jacob T. Robinson and Jamie Brannigan as speakers at its inaugural event, which was attended by researchers from leading institutions including King’s College London, Imperial College London, The Francis Crick Institute, and others.
The event on June 4th will explore the frontier of non-invasive brain-computer interface (BCI) technology, featuring two presentations.
Priority registration for this event will be given to researchers in physics, neuroscience, materials science, and engineering if space becomes limited. However, we encourage everyone passionate about the future of BCIs to register, as we’re already planning to expand capacity and customise the content for future events. Don’t miss your chance to be part of this transformative journey!
Preliminary Schedule
18.00 registration
18.15 opening remarks from vision 73
18.30 Nir Grossman, reflections on his research journey and developing novel strategies for electrical brain stimulation (offline)
19.15 Tamara Gerbert, From Hospital to Home: Reimagining closed-loop rTMS as Everyday Neural Care (offline)
20.00 Refreshments
Details
Nir Grossman
Nir is a Lecturer (Assistant Professor) in the Department of Brain Sciences and a founding fellow of the UK Dementia Research Institute centre at Imperial College London. He is also affiliated with Imperial’s Centre for Bioinspired Technology and Centre for Neurotechnology, MIT’s Media Lab and McGovern Institute for Brain Research.
Among other things, Nir was awarded the BBSRC (Biotechnology and Biological Sciences Research Council) Enterprise Fellowship and the Wellcome Trust MIT Fellowship. In 2018, Nir was awarded the Science & PINS Prize for Neuromodulation, for his pioneering work on noninvasive brain stimulation methods.
https://profiles.imperial.ac.uk/nirg
Tamara Gerbert
Tamara is the Founder of Brightmind.AI, a neurotechnology company developing at-home, personalized neuromodulation therapies. She holds degrees in Neuroscience from King’s College London and Neuroengineering from Imperial College London, and was named a Forbes 30 Under 30 honouree for her work at the intersection of AI and brain health.
Before founding Brightmind.AI, Tamara developed a machine learning model that outperformed clinicians in diagnosing Parkinson’s disease and worked at Cambrium, where she built AI tools for designing protein-based materials.
https://brightmind.ai/about-us/tamara-gerbert/
vision 73
vision 73 is a non-profit initiative, launched by Peter Zhegin and Vasyl Mykytiuk. During the day, Vasyl is a PhD student at the Francis Crick Institute and UCL and Peter is a Partner at e184, an advanced research funding organisation.
By leveraging events, coordination, and analytics, vision 73 aims to support transition of brain-computer interfaces from niche medical and research tools to groundbreaking general-purpose technologies.https://seventhree.org/
vision 73 